Search for a trial

An open label, single arm, extension trial to examine long-term safety of Iclepertin once daily in patients with schizophrenia who have completed previous Iclepertin Phase III trials (CONNEX-X).

This study has been transitioned to CTIS with ID 2024-511560-93-00 check the CTIS register for the current data. The objective of this trial is to collect additional safety data.The further objective of this trial is to collect long-term efficacy…